ASIC Corporations (Amendment) Instrument 2023/24

Administered by Department of the Treasury

Legislation au F2023L00059 Not in force Legislative Instrument

Legislation content

 

 

Explanatory Statement

 

ASIC Corporations (Amendment) Instrument 2023/24

This is the Explanatory Statement for ASIC Corporations (Amendment) Instrument 2023/24 (the instrument).

The Explanatory Statement is approved by the Australian Securities and Investments Commission (ASIC).

Summary

1. The instrument amends ASIC Corporations (Short Selling) Instrument 2018/745 (the Principal Instrument) to:

a. put beyond doubt the effect of a minor misdescribed amendment in ASIC Corporations (Short Selling) Amendment Instrument 2022/968 (Amending Instrument), and

b. make other minor clarifying changes to notional subsection 1020B(7H) of the Corporations Act 2001 (Corporations Act).

Purpose of the instrument

2. The purpose of the instrument is to:

a. clarify that the amendment made by item 15 of Schedule 1 to the Amending Instrument to Section 11 of the Principal Instrument has its intended effect; and

b. make other minor clarifying amendments to notional subsection 1020B(7H), which is inserted into the Corporations Act by Section 11 of the Principal Instrument.  

Consultation

3. ASIC did not consult on the instrument. The instrument merely puts beyond doubt the effect of a misdescribed amendment made by the Amending Instrument, and makes other minor clarifying amendments to the Principal Instrument that are not intended to affect its operation.

Operation of the instrument

 Name

4. Section 1 of the instrument provides that the instrument is the ASIC Corporations (Amendment) Instrument 2023/24.

 Commencement

5. Section 2 of the instrument provides that the instrument commences on the day after it is registered on the Federal Register of Legislation.

 Note:  The register may be accessed at www.legislation.gov.au

 Authority

6. Section 3 of the instrument provides that the instrument is made under subsection 1020F(1) of the Corporations Act.

 Schedules

7. Section 4 of the instrument provides that each instrument that is specified in a Schedule to the instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to the instrument has effect according to its terms.

 Schedule 1 – Amendments

8.  Item 1 of Schedule 1 repeals notional subsection 1020B(7H) of the Corporations Act and substitutes it as follows:

(7H) A person must only, in this jurisdiction, sell section 1020B products to a buyer on a licensed market during a deferred settlement trading period if, at the time of the sale:

(a) the person is or, if the person is selling on behalf of another person, that other person is; or

(b) the person believes on reasonable grounds that the person is or, if the person is selling on behalf of another person, that other person is;

in a class of persons who, because such persons hold financial products of a particular class, have an entitlement to be issued with or transferred the section 1020B products under or in connection with the corporate action.”.

9.      The effect of the substituted notional subsection 1020B(7H) is that it puts beyond doubt that the amendment is applicable to notional subsection 1020B(7H) and not notional paragraph 1020B(7H)(b) (as misdescribed in the Amending Instrument). The substitution also makes minor clarifications to notional subsection 1020B(7H), such as specifying either (7H)(a) or (b) are applicable by including ‘or’, and correcting the omission of ‘in’ for the purposes of ‘in connection.’

Legislative instrument and primary legislation  

10. The subject matter and policy implemented by the instrument is more appropriate for a legislative instrument rather than primary legislation. This is because its purpose is to put beyond doubt the effect of a misdescribed amendment by the Amending Instrument to notional subsection 1020B(7H) which is inserted into the Corporations Act by Section 11 of the Principal Instrument. The instrument also makes other minor clarifying amendments to notional subsection 1020B(7H).

11. It will be a matter for the Government and for Parliament as to whether the Corporations Act  or the Corporations Regulations 2001 may be amended in future to include the relief in the Principal Instrument.

Duration of the instrument

12. This instrument is automatically repealed by section 48A of the Legislation Act 2003 as its only legal affect is to amend another legislative instrument.

13. The Principal Instrument sunsets on 1 October 2028 in accordance with section 50 of the Legislation Act 2003.

Legislative authority

14. ASIC makes this instrument under subsection 1020F(1) of the Corporations Act.

15. Where an Act confers a power to make an instrument, the power is to be constructed as including a power exercisable in the like manner and subject to the like conditions to amend the instrument: see subsection 33(3) of the Acts Interpretation Act 1901 (as in force as at 1 January 2005, as per section 5C of the Corporations Act).

16. This instrument is a disallowable legislative instrument: see section 42 of the Legislation Act 2003.

Statement of Compatibility with Human Rights  

17. The Explanatory Statement for a disallowable legislative instrument must contain a Statement of Compatibility with Human Rights under subsection 9(1) of the Human Rights (Parliamentary Scrutiny) Act 2011. A Statement of Compatibility with Human Rights is in the Attachment.


Attachment

Statement of Compatibility with Human Rights

This Statement of Compatibility with Human Rights is prepared in accordance with Part 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.   

ASIC Corporations (Amendment) Instrument 2023/24

Overview

1. The ASIC Corporations (Amendment) Instrument 2023/24 (the instrument) amends ASIC Corporations (Short Selling) Instrument 2018/745 to:

a. put beyond doubt the effect of a minor misdescribed amendment in ASIC Corporations (Short Selling) Amendment Instrument 2022/968;

b. make other minor clarifying changes to notional subsection 1020B(7H) of the Corporations Act 2001.

Assessment of human rights implications

2. This instrument does not engage any of the applicable rights or freedoms.

Conclusion

3. This instrument is compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

 

Overview

The ASIC Corporations (Amendment) Instrument 2023/24 was introduced to address a minor misdescription in a previous amendment made by the ASIC Corporations (Short Selling) Amendment Instrument 2022/968, specifically concerning notional subsection 1020B(7H) of the Corporations Act 2001. The instrument aims to clarify the intended effect of this misdescription and to make minor clarifying amendments to ensure the proper operation of the regulations. Enacted by the Australian Securities and Investments Commission (ASIC) under the authority granted by the Corporations Act, the policy objective of this instrument is to rectify the misdescription without altering the fundamental operation of the existing regulations. ASIC did not consult on the instrument, as its changes are intended to be purely clarifying and non-operational, ensuring that the law remains clear and effectively enforced.

Scope and Application

The ASIC Corporations (Amendment) Instrument 2023/24 applies to entities and individuals involved in the sale of financial products under the Corporations Act 2001, particularly those conducting short selling transactions within Australia. This instrument amends the ASIC Corporations (Short Selling) Instrument 2018/745 to address a misdescribed amendment in the ASIC Corporations (Short Selling) Amendment Instrument 2022/968, ensuring the intended regulatory effect is achieved. Additionally, it makes minor clarifying changes to notional subsection 1020B(7H) of the Corporations Act. This instrument operates nationally across Australia and is applicable to all relevant financial entities and practitioners operating within the Australian securities market. The instrument does not specify any exclusions, exemptions, or thresholds but focuses on clarifying and correcting existing provisions to ensure proper enforcement and compliance with the Corporations Act. The application of the instrument may be further extended or restricted through subordinate instruments made under the authority of the Corporations Act.

Key Provisions

The ASIC Corporations (Amendment) Instrument 2023/24 (section 1) amends the ASIC Corporations (Short Selling) Instrument 2018/745 (section 4). The instrument seeks to clarify the effect of a misdescribed amendment made in the ASIC Corporations (Short Selling) Amendment Instrument 2022/968 (section 8) and make other minor clarifications to notional subsection 1020B(7H) of the Corporations Act 2001. The instrument comes into operation on the day after it is registered on the Federal Register of Legislation (section 2) and is made under subsection 1020F(1) of the Corporations Act (section 3). The instrument imposes specific obligations on entities involved in short selling under the Corporations Act. These obligations include ensuring that a seller is either in a class of persons with an entitlement to be issued with or transferred section 1020B products, or believes on reasonable grounds that they are, when selling such products on a licensed market during a deferred settlement trading period (notional subsection 1020B(7H)). The clarifications aim to ensure compliance with the intended legislative effect, particularly in relation to the seller's entitlement or belief regarding their entitlement to the products being sold. Breach of the provisions set out in this instrument could result in civil or criminal penalties under the Corporations Act. However, the specific maximum penalties are not detailed in the Explanatory Statement. The misdescribed amendment and the minor clarifications are intended to ensure that the provisions are correctly applied and enforced, thereby maintaining the integrity of the short selling regulatory framework. The instrument is automatically repealed under section 48A of the Legislation Act 2003 as its only legal effect is to amend another legislative instrument (section 12). The principal instrument, ASIC Corporations (Short Selling) Instrument 2018/745, sunsets on 1 October 2028 (section 13). The instrument is a disallowable legislative instrument, meaning it can be subject to disallowance by either House of Parliament (section 16). The instrument has been assessed for compatibility with human rights and is considered compatible with the human rights and freedoms recognised or declared in the international instruments listed in section 3 of the Human Rights (Parliamentary Scrutiny) Act 2011.

Legal classification tags

Area of Law
Corporate Law & Governance
Instrument
Statutory Instrument
Concepts
Definitions & Interpretation
Repeal & Amendment
Commencement Provisions
Delegated & Subordinate Legislation

Interactions

Authorises

All Versions

Sourced from the Federal Register of Legislation at 26 August 2026. For the latest information on Australian Government law please go to https://www.legislation.gov.au.